P

PCVX

PCVX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
PCVX Live QuoteReal-time
$58.36
$4.87(-7.70%)1M
Day Range$58.23 – $61.70
Open$58.89
Previous Close$58.52
Volume982.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$9.24B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-8.05
Price to Book3.7
Dividend Yield0.65%
Beta (Volatility)1.29
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $58.36 (33%)
Low: $42.40High: $90.75
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$116.40-22.4% upside

Insider Buys

0

$0

Insider Sales

40

$23.06M

Total Volume

$23.06M

40 transactions

Net Activity

$23.06M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
W
1

Wassil Jim

EVP, Chief Scientific Ofc, COO

0 buys15 sells

$5.94M total

P
2

Pickering Grant

CEO

0 buys5 sells

$5.24M total

G
3

Guggenhime Andrew

Pres, CFO

0 buys7 sells

$4.40M total

C
4

Cowan Elvia

SVP, Finance, CAO

0 buys5 sells

$2.71M total

D
5

Dhaliwal Harpreet S.

Chief Technical Ops Officer

0 buys3 sells

$2.54M total

Trading History
PCVX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Dhaliwal Harpreet S.

Chief Technical Ops Officer

CTO
Sell17.0K$67.83$1.15M

Nov 2, 2026

2 weeks ago

Cowan Elvia

SVP, Finance, CAO

SVP
Sell3.0K$60.92$183K

Nov 2, 2026

2 weeks ago

Wassil Jim

EVP, Chief Scientific Ofc, COO

COO
Sell2.3K$60.90$137K

Oct 5, 2026

1 months ago

Wassil Jim

EVP, Chief Scientific Ofc, COO

COO
Sell18.0K$86.74$1.56M

Oct 5, 2026

1 months ago

Cowan Elvia

SVP, Finance, CAO

SVP
Sell19.0K$86.74$1.65M

Oct 1, 2026

1 months ago

Wassil Jim

EVP, Chief Scientific Ofc, COO

COO
Sell2.3K$56.67$128K

Sep 4, 2026

2 months ago

Wassil Jim

EVP, Chief Scientific Ofc, COO

COO
Sell2.7K$60.35$164K

Sep 1, 2026

2 months ago

Wassil Jim

COO

COO
Sell3.5K$61.07$212K

Aug 5, 2026

3 months ago

Dhaliwal Harpreet S.

Chief Technical Ops Officer

CTO
Sell17.0K$55.00$935K

Aug 3, 2026

3 months ago

Wassil Jim

COO

COO
Sell2.3K$53.86$121K

Aug 3, 2026

3 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell10.0K$53.89$539K

Jul 27, 2026

3 months ago

Pickering Grant

CEO

CEO
Sell18.2K$55.63$1.01M

Jul 6, 2026

4 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell10.0K$57.28$573K

Jul 1, 2026

4 months ago

Wassil Jim

COO

COO
Sell2.3K$56.33$127K

Jun 26, 2026

4 months ago

Pickering Grant

CEO

CEO
Sell24.2K$55.22$1.34M

Jun 18, 2026

5 months ago

Pickering Grant

CEO

CEO
Sell24.5K$52.50$1.28M

Jun 18, 2026

5 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell10.0K$53.00$530K

Jun 1, 2026

5 months ago

Wassil Jim

COO

COO
Sell2.3K$49.52$111K

May 1, 2026

6 months ago

Wassil Jim

COO

COO
Sell2.3K$56.83$128K

Apr 7, 2026

7 months ago

Cowan Elvia

SVP, Finance, CAO

SVP
Sell3.0K$60.00$180K

Apr 1, 2026

7 months ago

Wassil Jim

COO

COO
Sell2.3K$58.43$131K

Mar 11, 2026

8 months ago

Cowan Elvia

SVP, Finance, CAO

SVP
Sell2.5K$58.59$146K

Mar 10, 2026

8 months ago

Wassil Jim

COO

COO
Sell7.4K$58.88$435K

Dec 31, 2025

10 months ago

Dhaliwal Harpreet S.

Chief Technical Ops Officer

CTO
Sell9.7K$46.69$455K

Dec 23, 2025

11 months ago

Cowan Elvia

SVP, Finance

SVP
Sell11.6K$47.92$557K

Mar 5, 2025

20 months ago

Eydelman Mikhail

SVP, GC, Corp Sec

SVP
Sell5.0K$70.74$354K

Mar 3, 2025

20 months ago

Wassil Jim

COO

COO
Sell8.0K$73.27$586K

Feb 18, 2025

21 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell8.0K$83.85$671K

Feb 5, 2025

21 months ago

Eydelman Mikhail

SVP, GC, Corp Sec

SVP
Sell5.0K$90.07$450K

Feb 3, 2025

21 months ago

Wassil Jim

COO

COO
Sell8.0K$86.22$690K

Jan 21, 2025

22 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell8.0K$86.51$692K

Jan 15, 2025

22 months ago

Loxam Teri

Dir

Director
Sell6.3K$85.11$532K

Jan 6, 2025

22 months ago

Eydelman Mikhail

SVP, GC, Corp Sec

SVP
Sell5.0K$85.58$428K

Jan 2, 2025

22 months ago

Wassil Jim

COO

COO
Sell8.0K$83.66$669K

Dec 18, 2024

23 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell8.0K$88.78$710K

Dec 9, 2024

23 months ago

Pickering Grant

CEO

CEO
Sell2.4K$92.25$218K

Dec 5, 2024

23 months ago

Eydelman Mikhail

SVP, GC, Corp Sec

SVP
Sell5.0K$91.49$457K

Dec 2, 2024

23 months ago

Pickering Grant

CEO

CEO
Sell15.0K$92.45$1.39M

Dec 2, 2024

23 months ago

Wassil Jim

COO

COO
Sell8.0K$92.49$740K

Nov 18, 2024

24 months ago

Guggenhime Andrew

Pres, CFO

CFO
Sell8.0K$85.81$687K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PCVX Buy Conviction0%
Industry Rank#312 of 569
Volume Contribution0.1%
Total Industry Activity$16.53B

PCVX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. PCVX ranks #312 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PCVX

Over the last 90 days, corporate insiders at PCVX (PCVX) engaged in a total of 40 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 40 were sales. The total volume of insider trading reached $23.06M.

The net insider activity for PCVX shows a net selling bias of $23.06M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Cowan Elvia (SVP, Finance, CAO), who traded 19.0K shares valued at $1.65M on Oct 5, 2026.

Live Market News & Developments
Aggregated real-time headlines for PCVX (PCVX)
6 updates

Wall Street Analysts See an 87.35% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?

Yahoo Finance21d ago

Vaxcyte Stock Hits New 52-Week High - Here’s Why

Benzinga46d ago

Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market

Investor's Business Daily46d ago

PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit ‘Blue-Sky’ Case

Yahoo Finance46d ago

PCVX Stock Builds Tension Ahead Of Key OPUS-1 Data

Timothy Sykes46d ago

PCVX Stock Heats Up As OPUS-1 Catalyst Looms Large

StocksToTrade46d ago

FAQs About PCVX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PCVX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PCVX is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 40 sales by company executives over the last 90 days.

The CEO Conviction Index for PCVX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.